製品の概要

  • 製品名Anti-C14orf133 antibody
  • 製品の詳細
    Rabbit polyclonal to C14orf133
  • アプリケーション適用あり: WB, IPmore details
  • 種交差性
    交差種: Mouse, Human
    交差が予測される動物種: Chimpanzee, Rhesus monkey, Gorilla, Orangutan
  • 免疫原

    Synthetic peptide, corresponding to a region between amino acids 443-493 of Human C14orf133 (NP_071350.2).

  • ポジティブ・コントロール
    • HeLa, 293T, Jurkat and NIH3T3 whole cell lysates.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • バッファーPreservative: 0.09% Sodium azide
    Constituent: 99% Tris citrate/phosphate
    Note: pH 7 to 8
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • 特記事項(精製)ab125084 was affinity purified using an epitope specific to C14orf133 immobilized on solid support.
  • ポリ/モノポリクローナル
  • アイソタイプIgG

アプリケーション

Our Abpromise guarantee covers the use of ab125084 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/2000 - 1/10000. Predicted molecular weight: 57 kDa.
IP Use at 2-10 µg/mg of lysate.

ターゲット情報

  • 機能Plays a role in lysosomal trafficking. May play a role in epithelial polarization through stabilization of apical membrane protein content, possibly via the RAB11A-dependent apical recycling pathway. Also involved in direct or indirect transcriptional regulation of E-cadherin.
  • 関連疾患Defects in VIPAR are the cause of arthrogryposis-renal dysfunction-cholestasis syndrome type 2 (ARCS2) [MIM:613404]. ARCS2 is an autosomal recessive multisystem disorder, characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity. Platelet dysfunction is common. Note=In liver, CEACAM5 and ABCB11 are mislocalized and E-cadherin expression is decreased.
  • 配列類似性Belongs to the VIPAR family.
  • 細胞内局在Early endosome. Recycling endosome. Late endosome.
  • Information by UniProt
  • 参照データベース
  • 別名
    • Apical basolateral polarity regulator antibody
    • FLJ12707 antibody
    • hSPE-39 antibody
    • Protein spe-39 homolog antibody
    • SPE 39 antibody
    • SPE 39 protein antibody
    • SPE39 antibody
    • Uncharacterized protein C14orf133 antibody
    • vipar antibody
    • VIPAR_HUMAN antibody
    • VPS16B antibody
    • VPS33B interacting protein antibody
    • VPS33B interacting protein apical basolateral polarity regulator antibody
    • VPS33B interacting protein involved in polarity and apical protein restriction antibody
    • VPS33B-interacting protein antibody
    see all

Anti-C14orf133 antibody 画像

  • All lanes : Anti-C14orf133 antibody (ab125084) at 0.1 µg/ml

    Lane 1 : HeLa whole cell lysate at 50 µg
    Lane 2 : HeLa whole cell lysate at 15 µg
    Lane 3 : 293T whole cell lysate at 50 µg
    Lane 4 : Jurkat whole cell lysate at 50 µg
    Lane 5 : NIH3T3 whole cell lysate at 50 µg

    Developed using the ECL technique

    Predicted band size : 57 kDa


    Exposure time : 30 seconds
  • Detection of C14orf133 by Western Blot of Immunprecipitate.
    ab125084 at 1µg/ml staining C14orf133 in HeLa whole cell lysate immunoprecipitated using ab125084 at 6µg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
    Detection: Chemiluminescence with exposure time of 30 seconds.

Anti-C14orf133 antibody (ab125084) 使用論文

ab125084 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab125084.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"